Demystifying the medical management of nephrolithiasis.

Abstract

Nephrolithiasis is a common problem associated with significant costs to the health care system. Its prevalence continues to increase, particularly in women, which is attributed to changes in diet and lifestyle. The costs associated with the evaluation and management of nephrolithiasis in the United States has been estimated to be $1.83 billion, and, without any intervention, the risk of recurrence is high. This article reviews the management options for nephrolithiasis including a new formulation of potassium citrate, Urocit®-K 15 mEq, that allows for dosing flexibility which can lead to improved compliance and tolerability.

• Authors: Michael E Lipkin, Glenn M Preminger
• Journal: Reviews in urology (Rev Urol) Vol. 13 Issue 1 Pg. 34-8 ( 2011) ISSN: 2153-8182 [Electronic] United States
• PMID: 21826126 (Publication Type: Journal Article)